Review of the evidence base of strategies to prevent ovarian hyperstimulation syndrome (Q36847973)

16 August 2017

1 reference

title

Review of the evidence base of strategies to prevent ovarian hyperstimulation syndrome (English)

1 reference

16 August 2017

Raj Mathur

1

1 reference

PubMed ID

17564886

16 August 2017

Chandra Kailasam

series ordinal

2

1 reference

PubMed ID

17564886

16 August 2017

Julian Jenkins

series ordinal

3

1 reference

16 August 2017

1 June 2007

1 reference

16 August 2017

1 reference

16 August 2017

10

1 reference

16 August 2017

2

1 reference

16 August 2017

75-85

1 reference

Serum vascular endothelial growth factor and Doppler blood flow velocities in in vitro fertilization: relevance to ovarian hyperstimulation syndrome and polycystic ovaries.

16 August 2017

1 reference

https://api.crossref.org/works/10.1080%2F14647270601111239

Severe ovarian hyperstimulation syndrome in assisted reproductive technology: definition of high risk groups

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14647270601111239

The use of intravenous albumin in patients at high risk for severe ovarian hyperstimulation syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14647270601111239

Follicular development and hormone concentrations following recombinant FSH administration for anovulation associated with polycystic ovarian syndrome: prospective, randomized comparison between low-dose step-up and modified step-down regimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14647270601111239

Intravenous albumin does not prevent moderate-severe ovarian hyperstimulation syndrome in high-risk IVF patients: a randomized controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14647270601111239

Withholding gonadotropin administration is an effective alternative for the prevention of ovarian hyperstimulation syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14647270601111239

The antral follicle count predicts the outcome of pregnancy in a controlled ovarian hyperstimulation/intrauterine insemination program

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14647270601111239

A comparative randomized multicentric study comparing the step-up versus step-down protocol in polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14647270601111239

Hormonal regulation of apoptosis in early antral follicles: follicle-stimulating hormone as a major survival factor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14647270601111239

A systematic review and meta-analysis of randomized controlled trials on metformin co-administration during gonadotrophin ovulation induction or IVF in women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14647270601111239

Updated meta-analysis of recombinant follicle-stimulating hormone (FSH) versus urinary FSH for ovarian stimulation in assisted reproduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14647270601111239

Embryo freezing for preventing ovarian hyperstimulation syndrome: a Cochrane review

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14647270601111239

New insights into the pathophysiology of ovarian hyperstimulation syndrome. What makes the difference between spontaneous and iatrogenic syndrome?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14647270601111239

Preventive attitude of physicians to avoid OHSS in IVF patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14647270601111239

Epidemiology and prevention of ovarian hyperstimulation syndrome (OHSS): a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14647270601111239

A qualitative systematic review of coasting, a procedure to avoid ovarian hyperstimulation syndrome in IVF patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14647270601111239

The ovarian hyperstimulation syndrome in in-vitro fertilization: a Belgian multicentric study. I. Clinical and biological features.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14647270601111239

Prevention of severe ovarian hyperstimulation by coasting.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14647270601111239

Insulin activates vascular endothelial growth factor in vascular smooth muscle cells: influence of nitric oxide and of insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14647270601111239

Timed unilateral ovarian follicular aspiration prior to administration of human chorionic gonadotrophin for the prevention of severe ovarian hyperstimulation syndrome in in-vitro fertilization: a prospective randomized study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14647270601111239

Early unilateral follicular aspiration compared with coasting for the prevention of severe ovarian hyperstimulation syndrome: a prospective randomized study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14647270601111239

Continuation of GnRH agonist administration for 1 week, after hCG injection, prevents ovarian hyperstimulation syndrome following elective cryopreservation of all pronucleate embryos

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14647270601111239

Prospective study of the clinical and laboratory parameters of patients in whom ovarian hyperstimulation syndrome developed during controlled ovarian hyperstimulation for in vitro fertilization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14647270601111239

Elective cryopreservation of all pronucleate embryos in women at risk of ovarian hyperstimulation syndrome: efficiency and safety.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14647270601111239

Coasting for the prevention of ovarian hyperstimulation syndrome: much ado about nothing?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14647270601111239

Intravenous albumin versus hydroxyethyl starch for the prevention of ovarian hyperstimulation in an in-vitro fertilization programme: a prospective randomized placebo controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14647270601111239

Reduced incidence of ovarian hyperstimulation syndrome by prophylactic infusion of hydroxyaethyl starch solution in an in-vitro fertilization programme

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14647270601111239

Low-dose FSH therapy for anovulatory infertility associated with polycystic ovary syndrome: rationale, results, reflections and refinements

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14647270601111239

Luteolysis induced by a gonadotropin-releasing hormone agonist is the key to prevention of ovarian hyperstimulation syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14647270601111239

A lower ongoing pregnancy rate can be expected when GnRH agonist is used for triggering final oocyte maturation instead of HCG in patients undergoing IVF with GnRH antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14647270601111239

Metformin in polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14647270601111239

Use of GnRH antagonists in ovarian stimulation for assisted reproductive technologies compared to the long protocol. Meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14647270601111239

A controlled study comparing patients with and without polycystic ovaries undergoing in-vitro fertilization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14647270601111239

Criteria of a successful coasting protocol for the prevention of severe ovarian hyperstimulation syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14647270601111239

A low-dose stimulation protocol using highly purified follicle-stimulating hormone can lead to high pregnancy rates in in vitro fertilization patients with polycystic ovaries who are at risk of a high ovarian response to gonadotropins

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14647270601111239

Ovarian hyperstimulation syndrome may be more likely if multiple pregnancy occurs following assisted conception

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14647270601111239

Distinction between early and late ovarian hyperstimulation syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14647270601111239

Serum vascular endothelial growth factor levels are poorly predictive of subsequent ovarian hyperstimulation syndrome in highly responsive women undergoing assisted conception

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14647270601111239

Inhibition of ovarian-derived prorenin to angiotensin cascade in the treatment of ovarian hyperstimulation syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14647270601111239

Can we eliminate severe ovarian hyperstimulation syndrome?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14647270601111239

A randomized controlled trial evaluating metformin pre-treatment and co-administration in non-obese insulin-resistant women with polycystic ovary syndrome treated with controlled ovarian stimulation plus timed intercourse or intrauterine inseminatio

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14647270601111239

Plasma levels of soluble vascular endothelial growth factor receptor-1 may determine the onset of early and late ovarian hyperstimulation syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14647270601111239

The use of laparoscopic ovarian electrocautery in preventing cancellation of in-vitro fertilization treatment cycles due to risk of ovarian hyperstimulation syndrome in women with polycystic ovaries

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14647270601111239

Prevention and treatment of ovarian hyperstimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14647270601111239

Unilateral follicular aspiration and in-vitro maturation before contralateral oocyte retrieval: a method to prevent ovarian hyperstimulation syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14647270601111239

Prevention of severe ovarian hyperstimulation syndrome (OHSS) in IVF patients by steroidal ovarian suppression--a prospective randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14647270601111239

The use of metformin for women with PCOS undergoing IVF treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14647270601111239

"Coasting" does not adversely affect cycle outcome in a subset of highly responsive in vitro fertilization patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14647270601111239

Does laparoscopic ovarian diathermy affect the outcome of IVF-embryo transfer in women with polycystic ovarian syndrome? A retrospective comparative study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14647270601111239

The effects of 'coasting' on follicular fluid concentrations of vascular endothelial growth factor in women at risk of developing ovarian hyperstimulation syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14647270601111239

Follicular aspiration during the selection phase prevents severe ovarian hyperstimulation in patients with polycystic ovary syndrome who are undergoing in vitro fertilization

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14647270601111239

10.1080/14647270601111239

21 January 2018

Identifiers

DOI

1 reference

16 August 2017

1 reference

PubMed ID

17564886